Hennion & Walsh Asset Management »

Rapt Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $401k 45k 8.98
2023-12-31 $1.1M 44k 24.85
2023-09-30 $674k 41k 16.62
2023-06-30 $400k 21k 18.69

More positions owned by Hennion & Walsh Asset Management

Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Intl Qulty Div (IQDG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Investment Grade (IGEB)
Wisdomtree Tr Us S Cap Qty Div (DGRS)
Nuveen Div. Advantage Muni. Fund (NAD)
Ishares Core Msci Emkt (IEMG)
Nuveen Insured Tax-Free Adv Munici (NEA)
Eli Lilly & Co. (LLY)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Global X Fds Us Pfd Etf (PFFD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)

View all positions for Hennion & Walsh Asset Management

Top funds holding Rapt Therapeutics

T. Rowe Price Associates
Column Group
Perceptive Advisors
Vanguard Group
Dr. Jeffrey R. Jay, M.D.
Kingdon Capital Management
Samlyn Capital
Euclidean Capital
Alphabet
Cormorant Asset Management
Dimensional Fund Advisors
Millennium Management
Citadel Advisors
Braidwell
Redmile Group

View all funds holding Rapt Therapeutics